LENZ Therapeutics (LENZ) Institutional Ownership $32.63 +2.35 (+7.76%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)CurrentInstitutional OwnershipPercentage54.32%Number ofInstitutional Buyers(last 12 months)28TotalInstitutional Inflows(last 12 months)$118.99MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$945.66K Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LENZ Institutional Buying and Selling by Quarter Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. LENZ Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC16,463$391K0.0%+273.1%0.060% 11/16/2024 Geode Capital Management LLC338,024$8.03M0.0%-6.1%1.229% 11/15/2024 Barclays PLC16,463$391K0.0%+273.1%0.060% 11/15/2024 Jane Street Group LLC12,027$286K0.0%N/A0.044% 11/15/2024 Wellington Management Group LLP24,621$585K0.0%N/A0.090% 11/15/2024 State Street Corp289,154$6.87M0.0%+18.7%1.051% Get the Latest News and Ratings for LENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Parkman Healthcare Partners LLC139,357$3.31M0.4%N/A0.507% 11/14/2024 BBR Partners LLC40,000$950K0.1%+100.0%0.145% 11/14/2024 MetLife Investment Management LLC7,672$182K0.0%N/A0.028% 11/13/2024 BNP Paribas Financial Markets2,648$63K0.0%-83.9%0.010% 11/13/2024 The Manufacturers Life Insurance Company31,309$743K0.0%N/A0.114% 11/12/2024 Charles Schwab Investment Management Inc.123,371$2.93M0.0%+197.5%0.449% 11/5/2024 BML Capital Management LLC60,000$1.42M0.8%-6.1%0.218% 11/5/2024 GSA Capital Partners LLP10,357$246K0.0%N/A0.038% 10/3/2024 SG Americas Securities LLC4,523$107K0.0%N/A0.124% 8/15/2024 Deerfield Management Company L.P. Series C17,353$300K0.0%N/A0.476% 8/14/2024 Squarepoint Ops LLC10,477$181K0.0%N/A0.287% 8/14/2024 Marshall Wace LLP22,554$390K0.0%N/A0.618% 8/9/2024 Renaissance Technologies LLC60,166$1.04M0.0%+28.4%1.649% 8/9/2024 Dimensional Fund Advisors LP37,190$644K0.0%+58.0%1.019% 8/5/2024 BBR Partners LLC20,000$346K0.0%N/A0.548% 8/1/2024 Rhumbline Advisers16,812$291K0.0%+265.6%0.461% 7/26/2024 Bank of New York Mellon Corp39,737$687K0.0%+255.4%1.089% 7/16/2024 Wealth Enhancement Advisory Services LLC83,103$1.44M0.0%N/A2.277% 5/17/2024 RA Capital Management L.P.4,178,823$93.31M1.2%N/A114.488% 5/17/2024 Ikarian Capital LLC85,000$1.90M0.2%N/A2.329% 5/16/2024 Jacobs Levy Equity Management Inc.37,176$830K0.0%N/A1.019% 5/14/2024 American International Group Inc.1,973$44K0.0%N/A0.054% 5/10/2024 Vanguard Group Inc.206,952$4.62M0.0%N/A5.670% 5/7/2024 Marquette Asset Management LLC5,865$131K0.0%N/A0.161% 5/2/2024 Jennison Associates LLC134,740$3.01M0.0%N/A3.692% 5/1/2024 BNP Paribas Financial Markets16,221$362K0.0%N/A0.444% 4/25/2024 BML Capital Management LLC63,916$1.43M0.9%N/A1.751% (Data available from 1/1/2016 forward) LENZ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LENZ shares? During the previous two years, 29 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($93.31M), Geode Capital Management LLC ($8.03M), State Street Corp ($6.87M), Vanguard Group Inc. ($4.62M), Parkman Healthcare Partners LLC ($3.31M), Jennison Associates LLC ($3.01M), and Charles Schwab Investment Management Inc. ($2.93M).Learn more on LENZ's institutional investors. What percentage of LENZ Therapeutics stock is owned by institutional investors? 54.32% of LENZ Therapeutics stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings. Which institutional investors have been buying LENZ Therapeutics stock? Of the 28 institutional investors that purchased LENZ Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.18M), Vanguard Group Inc. ($206.95K), Parkman Healthcare Partners LLC ($139.36K), Jennison Associates LLC ($134.74K), Ikarian Capital LLC ($85K), Wealth Enhancement Advisory Services LLC ($83.10K), and Charles Schwab Investment Management Inc. ($81.90K). How much institutional buying is happening at LENZ Therapeutics? Institutional investors have bought a total of 5,353,345 shares in the last 24 months. This purchase volume represents approximately $118.99M in transactions. Which LENZ Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LENZ Therapeutics stock in the last 24 months: Geode Capital Management LLC ($22.10K), BNP Paribas Financial Markets ($13.82K), and BML Capital Management LLC ($3.92K). How much institutional selling is happening at LENZ Therapeutics? Institutional investors have sold a total of 39,834 shares in the last 24 months. This volume of shares sold represents approximately $945.66K in transactions. Related Companies DNLI Institutional Ownership TWST Institutional Ownership VCEL Institutional Ownership SWTX Institutional Ownership KYMR Institutional Ownership IOVA Institutional Ownership BEAM Institutional Ownership RXRX Institutional Ownership APGE Institutional Ownership IBRX Institutional Ownership This page (NASDAQ:LENZ) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
